Tate & Lyle PLC
Holding(s) in Company
Tate & Lyle PLC (the 'Company') was informed on 28 November 2006 that as at 22
November 2006 AMVESCAP PLC ('AMVESCAP') and subsidiary companies on behalf of
discretionary clients have a notifiable interest for the purposes of Part VI of
the Companies Act 1985 in 49,136,431 ordinary shares in the Company, being 10.03
per cent. of the ordinary share capital. These shares are registered in the
names of various legal entities listed below.
AMVESCAP advised the Company that none of these shares are beneficially held by
AMVESCAP. AMVESCAP had not previously reported an interest in the ordinary
shares of the Company.
-0-
*T
Registered Holder Holding
------------------------------------------------------ ---------------
Bank of Ireland (Dublin) 435,824
Bank of New York 278,651
Banque Paribas 421,457
Banque Paribas (Frankfurt) 160,228
Bank of New York (Brussels) 31,630
Credit Agricole Indosuez (Luxembourg) 127,423
JP Morgan Chase 70,860
Chase Nominees 1,530,708
Vidacos Nominees 38,860,302
HSBC Nominees 135,750
Japan Trustee Services Bank 1,481
Mellon Bank, Pittsburgh 473,451
Santander Central Hispano Investment 18,990
State Street Trust & Banking Co (London) 5,801,752
Trust & Custody Services JP 3,553
Northern Trust Company (London) 784,371
*T
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.